A Phase II Randomized, Double-blind, Placebo-Controlled Clinical Trial to Study the Efficacy and Safety of Bicalutamide with or without Deforolimus...
Name
Merck and Company
Anticipated Amount
11 250.00
Activity Type
Clinical Trial
Award Type
Contract
Date
June 26, 2010 to July 15, 2010
Award Number
003157-00001
Sponsor Award Number
ck#1000021005
Award Contacts
Name
Ahmann,Frederick R
Title
Principal Investigator
Unit
Cancer Center Division